Recombinant activated factor VII combined with desmopressin in preventing bleeding from dental extraction in a patient with Glanzmann's thrombasthenia

Clinical and Applied Thrombosis/Hemostasis

Volumn 12, Issue 1, 2006, Pages 115-116

  Lombardo, Vincenzo Trapani ^a,b   Sottilotta, Gianluca ^a  

^a BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^b NONE   (Italy)

Author keywords

Dental extraction; Glanzmann's thrombasthenia; Recombinant activated factor VII

Indexed keywords

DESMOPRESSIN; EMOSINT; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ADULT; ARTICLE; BLEEDING; BLEEDING TIME; CASE REPORT; DRUG EFFICACY; DRUG INFUSION; EPISTAXIS; FEMALE; GLANZMANN DISEASE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MENORRHAGIA; PRIORITY JOURNAL; PROTHROMBIN TIME; PURPURA; TOOTH EXTRACTION;

ADULT; BLOOD LOSS, SURGICAL; DEAMINO ARGININE VASOPRESSIN; DRUG THERAPY, COMBINATION; FACTOR VII; FEMALE; HUMANS; RECOMBINANT PROTEINS; THROMBASTHENIA; TOOTH EXTRACTION;

EID: 32244449445     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960601200120     Document Type: Article

References (7)

1. George JN, Caen JP, Nurden AT. Glanzmann's thrombasthenia: The spectrum of clinical disease. Blood 1990;75(7):1383.
2. Bell JA, Savidge GF. Glanzmann's thrombasthenia proposed optimal management during surgery and delivery. Clin Appl Thromb Hemost 2003;9(2):167.
3. Rao AK, Gosh S, Sun L, et al. Mechanisms of platelet dysfunction and response to DDAVP in patients with congenital platelet function defects. A double-blind placebo-controlled trial. Thromb Haemost 1995;74(4):1071.
4. Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders; the first twenty years. Haemophilia 2000;6(Suppl 1):60.
5. Galan AM, Tonda R, Pino M, et al. Increased local procoagulant action: A mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders. Transfusion 2003;43(7):885.
6. Laurian Y. Treatment of bleeding in patients with platelet disorders: Is there a place for recombinant factor VIIa? Pathophysiol Haemost Thromb 2002;32(Suppl 1):37.
7. Poon MC, D'Oiron R, Von Depka M, et al. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: Results of an international survey. J Thromb Haemost 2004;2(7):1096.